FeesSafety
Pluang+

Blue Owl acquires 34 bank branches from Trustmark with long-term leases securing steady income.

Company Fundamentals
17 Sep 2026
PRNewsWire
View Source
Bullish
Blue Owl acquires 34 bank branches from Trustmark with long-term leases securing steady income.

Blue Owl Capital's Real Assets platform has acquired 34 bank branch properties from Trustmark Corporation across five U.S. states. Trustmark entered into long-term triple net leases for all properties, ensuring Blue Owl receives stable rental income backed by an investment-grade bank. This deal allows Trustmark to optimize its balance sheet by converting real estate into capital while maintaining customer service. Each lease has an initial 15-year term with options to renew, highlighting a strategic partnership benefiting both parties in today's financial environment.

Blue Owl Capital's recent sale-leaseback transaction with Trustmark is presented here with relevant market data. For readers following the Financials sector, 52 of 74 US stocks traded on Pluang rose while 20 fell. MAIN was priced at USD 57.60 with a 1-day change of +2.42%, APO at USD 127.48 with +2.37%, and NDAQ at USD 90.79 with +2.29%. This data is as of Sep 17, 2026 22:21 WIB.

More News

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...

Company Fundamentals
Bullish
49 minutes ago
Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...

Company Fundamentals
Bullish
49 minutes ago
AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...

Others
Neutral
3 hours ago
Ethereum co-founder predicts AI and crypto will merge to enable trusted automated work on blockchain.

Ethereum co-founder predicts AI and crypto will merge to enable trusted automated work on blockchain.

Joseph Lubin, co-founder of Ethereum, predicts that artificial intelligence (AI) and cryptocurrency will merge on the Ethereum blockchain to create a system where automated tasks are commissioned, completed, and paid for with trust guaranteed by bloc...

Protocol Fundamentals
Bullish
4 hours ago
Bitcoin dips near $80K amid lower trading volume and rising exchange reserves, signaling cautious market sentiment.

Bitcoin dips near $80K amid lower trading volume and rising exchange reserves, signaling cautious market sentiment.

Bitcoin's price dropped to around $80,494, down 1.26%, alongside a 14.11% decline in trading volume, indicating weaker market participation. Despite increased network activity and a slight rise in Bitcoin's market dominance, sentiment remained neutra...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App